Want to join the conversation?
In 2Q16, $MNK posted net sales of $535MM in its Specialty Brands segment, an increase of 60% from 2Q15. In the Specialty Generics segment, net sales decreased 27.1% to $264.4MM, driven principally by net sales declines in various product categories due to increased competition. Net sales for the Nuclear Imaging segment were $102.2MM.
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?
$YHOO is reporting today after market close. Nobody cares about this stock.